Safety assessment of ezetimibe: real-world adverse event analysis from the FAERS database
Ezetimibe is effective in lowering blood lipids, but there is a risk of adverse reactions such as unstable angina, rhabdomyolysis and autoscopy, which require careful monitoring by physicians.
Authors
- Yuchen Han (ORCID: https://orcid.org/0000-0003-1308-4197)
- Jinzheng He
- Shaojie Han (ORCID: https://orcid.org/0000-0002-9758-4932)
- Lishuai Zhang (ORCID: https://orcid.org/0009-0002-8588-6682)
- Yang Yang (ORCID: https://orcid.org/0000-0002-6572-9068)
- Mingzheng Zhang (ORCID: https://orcid.org/0000-0002-3630-5258)
- Jun Guo
- Siyuan Cheng (ORCID: https://orcid.org/0000-0001-8601-2165)
Institutions
- Jinan University (CN)
- Red Cross Hospital (GR)
- First Affiliated Hospital of Jinan University (CN)
- Imperial College London (GB)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1080/14740338.2024.2446411
- Citations
- 2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 1.15